Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark E. Burnett
Mark E. Burnett
Medicine
SOD1
Dermatology
Superoxide dismutase
Immunology
5
Papers
258
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Lipophagic Panniculitis of Childhood: A Case Report and Comprehensive Review of the Literature
2017
American Journal of Dermatopathology
Jack Levy
Mark E. Burnett
Cynthia M. Magro
Show All
Source
Cite
Save
Citations (8)
Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium.
2012
The Journal of clinical and aesthetic dermatology
Sebastian G. Bernardo
Jason Emer
Mark E. Burnett
Marsha Gordon
Show All
Source
Cite
Save
Citations (8)
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling
2008
Proceedings of the National Academy of Sciences of the United States of America
Jose Juarez
Mari Manuia
Mark E. Burnett
Oscar Betancourt
Benoit Boivin
David E. Shaw
Nicholas K. Tonks
Andrew P. Mazar
Fernando Donate
Show All
Source
Cite
Save
Citations (193)
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
2008
British Journal of Cancer
Fernando Donate
Jose Juarez
Mark E. Burnett
Mari Manuia
Xiaojun Guan
David E. Shaw
Eric L.P. Smith
C Timucin
Marc Braunstein
Olcay Batuman
Andrew P. Mazar
Show All
Source
Cite
Save
Citations (49)
411 POSTER SOD1 inhibition by tetrathiomolybdate demonstrates differential sensitivity against melanoma cell lines in vitro and in vivo: a possible method for identifying patients most likely to benefit from the second generation tetrathiomolybdate, ATN-224
2006
Ejc Supplements
Fernando Donate
Jose Juarez
M. Maunia
Mark E. Burnett
Valerie Trapp
J. Fruehaut
Andrew P. Mazar
Show All
Source
Cite
Save
Citations (0)
1